Page last updated: 2024-11-11

nematophin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

nematophin: isolated from Xenorhabdus nematophilus; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID9881952
CHEMBL ID26598
CHEBI ID182456
MeSH IDM0283758

Synonyms (7)

Synonym
CHEBI:182456
n-[2-(1h-indol-3-yl)ethyl]-3-methyl-2-oxopentanamide
pentanamide, n-[2-(1h-indol-3-yl)ethyl]-3-methyl-2-oxo-
CHEMBL26598
nematophin
183314-24-1
DTXSID00432322
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
indolesAny compound containing an indole skeleton.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (39)

Assay IDTitleYearJournalArticle
AID207068In vitro inhibitory activity in iso sensitest agar against Staphylococcus aureus strain ATCC 29213 in addition with 5%serum1998Bioorganic & medicinal chemistry letters, Aug-04, Volume: 8, Issue:15
Synthesis and antibacterial in vitro activity of novel analogues of nematophin.
AID207067In vitro inhibitory activity in iso sensitest agar against Staphylococcus aureus strain ATCC 29213 in addition with 5%blood; Not tested1998Bioorganic & medicinal chemistry letters, Aug-04, Volume: 8, Issue:15
Synthesis and antibacterial in vitro activity of novel analogues of nematophin.
AID206657In vitro inhibitory activity in iso sensitest agar against Staphylococcus intermedius strain ATCC 296631998Bioorganic & medicinal chemistry letters, Aug-04, Volume: 8, Issue:15
Synthesis and antibacterial in vitro activity of novel analogues of nematophin.
AID206527In vitro inhibitory activity in iso sensitest agar against Staphylococcus hyicus strain ATCC 9621 in addition with 5%serum1998Bioorganic & medicinal chemistry letters, Aug-04, Volume: 8, Issue:15
Synthesis and antibacterial in vitro activity of novel analogues of nematophin.
AID206662In vitro inhibitory activity in iso sensitest agar against Staphylococcus intermedius strain ATCC 95031998Bioorganic & medicinal chemistry letters, Aug-04, Volume: 8, Issue:15
Synthesis and antibacterial in vitro activity of novel analogues of nematophin.
AID206525In vitro inhibitory activity in iso sensitest agar against Staphylococcus hyicus strain ATCC 9621 in addition with 0.5%serum1998Bioorganic & medicinal chemistry letters, Aug-04, Volume: 8, Issue:15
Synthesis and antibacterial in vitro activity of novel analogues of nematophin.
AID206528In vitro inhibitory activity in iso sensitest agar against Staphylococcus hyicus strain ATCC 96221998Bioorganic & medicinal chemistry letters, Aug-04, Volume: 8, Issue:15
Synthesis and antibacterial in vitro activity of novel analogues of nematophin.
AID207065In vitro inhibitory activity in iso sensitest agar against Staphylococcus aureus strain ATCC 29213 in addition with 0.5%blood; Not tested1998Bioorganic & medicinal chemistry letters, Aug-04, Volume: 8, Issue:15
Synthesis and antibacterial in vitro activity of novel analogues of nematophin.
AID206523In vitro inhibitory activity in iso sensitest agar against Staphylococcus hyicus strain ATCC 96211998Bioorganic & medicinal chemistry letters, Aug-04, Volume: 8, Issue:15
Synthesis and antibacterial in vitro activity of novel analogues of nematophin.
AID206532In vitro inhibitory activity in iso sensitest agar against Staphylococcus hyicus strain ATCC 9622 in addition with 5%serum1998Bioorganic & medicinal chemistry letters, Aug-04, Volume: 8, Issue:15
Synthesis and antibacterial in vitro activity of novel analogues of nematophin.
AID207074In vitro inhibitory activity in iso sensitest agar against Staphylococcus aureus strain ATCC 6538 in addition with 5%serum1998Bioorganic & medicinal chemistry letters, Aug-04, Volume: 8, Issue:15
Synthesis and antibacterial in vitro activity of novel analogues of nematophin.
AID206673In vitro inhibitory activity in iso sensitest agar against Staphylococcus intermedius strain ATCC 9503 in addition with 5%serum1998Bioorganic & medicinal chemistry letters, Aug-04, Volume: 8, Issue:15
Synthesis and antibacterial in vitro activity of novel analogues of nematophin.
AID206672In vitro inhibitory activity in iso sensitest agar against Staphylococcus intermedius strain ATCC 9503 in addition with 5%blood1998Bioorganic & medicinal chemistry letters, Aug-04, Volume: 8, Issue:15
Synthesis and antibacterial in vitro activity of novel analogues of nematophin.
AID207073In vitro inhibitory activity in iso sensitest agar against Staphylococcus aureus strain ATCC 6538 in addition with 5%blood1998Bioorganic & medicinal chemistry letters, Aug-04, Volume: 8, Issue:15
Synthesis and antibacterial in vitro activity of novel analogues of nematophin.
AID207059In vitro inhibitory activity in iso sensitest agar against Staphylococcus aureus strain ATCC 25923 in addition with 0.5%blood; Not tested1998Bioorganic & medicinal chemistry letters, Aug-04, Volume: 8, Issue:15
Synthesis and antibacterial in vitro activity of novel analogues of nematophin.
AID206670In vitro inhibitory activity in iso sensitest agar against Staphylococcus intermedius strain ATCC 9503 in addition with 0.5%blood1998Bioorganic & medicinal chemistry letters, Aug-04, Volume: 8, Issue:15
Synthesis and antibacterial in vitro activity of novel analogues of nematophin.
AID206671In vitro inhibitory activity in iso sensitest agar against Staphylococcus intermedius strain ATCC 9503 in addition with 0.5%serum1998Bioorganic & medicinal chemistry letters, Aug-04, Volume: 8, Issue:15
Synthesis and antibacterial in vitro activity of novel analogues of nematophin.
AID207791Minimum inhibitory concentration against methicillin sensitive organism Staphylococcus aureus 8532000Bioorganic & medicinal chemistry letters, Aug-07, Volume: 10, Issue:15
Studies on the novel anti-staphyloccal compound nematophin.
AID207064In vitro inhibitory activity in iso sensitest agar against Staphylococcus aureus strain ATCC 292131998Bioorganic & medicinal chemistry letters, Aug-04, Volume: 8, Issue:15
Synthesis and antibacterial in vitro activity of novel analogues of nematophin.
AID40763Minimum inhibitory concentration against Bacillus subtilis2000Bioorganic & medicinal chemistry letters, Aug-07, Volume: 10, Issue:15
Studies on the novel anti-staphyloccal compound nematophin.
AID206530In vitro inhibitory activity in iso sensitest agar against Staphylococcus hyicus strain ATCC 9622 in addition with 0.5%serum1998Bioorganic & medicinal chemistry letters, Aug-04, Volume: 8, Issue:15
Synthesis and antibacterial in vitro activity of novel analogues of nematophin.
AID207066In vitro inhibitory activity in iso sensitest agar against Staphylococcus aureus strain ATCC 29213 in addition with 0.5%serum; Not tested1998Bioorganic & medicinal chemistry letters, Aug-04, Volume: 8, Issue:15
Synthesis and antibacterial in vitro activity of novel analogues of nematophin.
AID206531In vitro inhibitory activity in iso sensitest agar against Staphylococcus hyicus strain ATCC 9622 in addition with 5%blood1998Bioorganic & medicinal chemistry letters, Aug-04, Volume: 8, Issue:15
Synthesis and antibacterial in vitro activity of novel analogues of nematophin.
AID206524In vitro inhibitory activity in iso sensitest agar against Staphylococcus hyicus strain ATCC 9621 in addition with 0.5%blood1998Bioorganic & medicinal chemistry letters, Aug-04, Volume: 8, Issue:15
Synthesis and antibacterial in vitro activity of novel analogues of nematophin.
AID207071In vitro inhibitory activity in iso sensitest agar against Staphylococcus aureus strain ATCC 6538 in addition with 0.5%blood1998Bioorganic & medicinal chemistry letters, Aug-04, Volume: 8, Issue:15
Synthesis and antibacterial in vitro activity of novel analogues of nematophin.
AID207070In vitro inhibitory activity in iso sensitest agar against Staphylococcus aureus strain ATCC 65381998Bioorganic & medicinal chemistry letters, Aug-04, Volume: 8, Issue:15
Synthesis and antibacterial in vitro activity of novel analogues of nematophin.
AID206526In vitro inhibitory activity in iso sensitest agar against Staphylococcus hyicus strain ATCC 9621 in addition with 5%blood1998Bioorganic & medicinal chemistry letters, Aug-04, Volume: 8, Issue:15
Synthesis and antibacterial in vitro activity of novel analogues of nematophin.
AID207072In vitro inhibitory activity in iso sensitest agar against Staphylococcus aureus strain ATCC 6538 in addition with 0.5%serum1998Bioorganic & medicinal chemistry letters, Aug-04, Volume: 8, Issue:15
Synthesis and antibacterial in vitro activity of novel analogues of nematophin.
AID207060In vitro inhibitory activity in iso sensitest agar against Staphylococcus aureus strain ATCC 25923 in addition with 0.5%serum; Not tested1998Bioorganic & medicinal chemistry letters, Aug-04, Volume: 8, Issue:15
Synthesis and antibacterial in vitro activity of novel analogues of nematophin.
AID207062In vitro inhibitory activity in iso sensitest agar against Staphylococcus aureus strain ATCC 25923 in addition with 5%serum1998Bioorganic & medicinal chemistry letters, Aug-04, Volume: 8, Issue:15
Synthesis and antibacterial in vitro activity of novel analogues of nematophin.
AID207058In vitro inhibitory activity in iso sensitest agar against Staphylococcus aureus strain ATCC 259231998Bioorganic & medicinal chemistry letters, Aug-04, Volume: 8, Issue:15
Synthesis and antibacterial in vitro activity of novel analogues of nematophin.
AID207061In vitro inhibitory activity in iso sensitest agar against Staphylococcus aureus strain ATCC 25923 in addition with 5%blood; Not tested1998Bioorganic & medicinal chemistry letters, Aug-04, Volume: 8, Issue:15
Synthesis and antibacterial in vitro activity of novel analogues of nematophin.
AID206669In vitro inhibitory activity in iso sensitest agar against Staphylococcus intermedius strain ATCC 29663 in addition with 5%serum1998Bioorganic & medicinal chemistry letters, Aug-04, Volume: 8, Issue:15
Synthesis and antibacterial in vitro activity of novel analogues of nematophin.
AID206667In vitro inhibitory activity in iso sensitest agar against Staphylococcus intermedius strain ATCC 29663 in addition with 0.5%serum; Not tested1998Bioorganic & medicinal chemistry letters, Aug-04, Volume: 8, Issue:15
Synthesis and antibacterial in vitro activity of novel analogues of nematophin.
AID206666In vitro inhibitory activity in iso sensitest agar against Staphylococcus intermedius strain ATCC 29663 in addition with 0.5%blood; Not tested1998Bioorganic & medicinal chemistry letters, Aug-04, Volume: 8, Issue:15
Synthesis and antibacterial in vitro activity of novel analogues of nematophin.
AID206668In vitro inhibitory activity in iso sensitest agar against Staphylococcus intermedius strain ATCC 29663 in addition with 5%blood; Not tested1998Bioorganic & medicinal chemistry letters, Aug-04, Volume: 8, Issue:15
Synthesis and antibacterial in vitro activity of novel analogues of nematophin.
AID207785Activity against methicillin sensitive organism Staphylococcus aureus 853 in presence of serum.2000Bioorganic & medicinal chemistry letters, Aug-07, Volume: 10, Issue:15
Studies on the novel anti-staphyloccal compound nematophin.
AID207790Minimum inhibitory concentration against methicillin resistant organism Staphylococcus aureus COL2000Bioorganic & medicinal chemistry letters, Aug-07, Volume: 10, Issue:15
Studies on the novel anti-staphyloccal compound nematophin.
AID206529In vitro inhibitory activity in iso sensitest agar against Staphylococcus hyicus strain ATCC 9622 in addition with 0.5%blood1998Bioorganic & medicinal chemistry letters, Aug-04, Volume: 8, Issue:15
Synthesis and antibacterial in vitro activity of novel analogues of nematophin.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (25.00)18.2507
2000's3 (37.50)29.6817
2010's3 (37.50)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.38

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.38 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.58 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.38)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]